Skip to content

Year in Brief

The  Johnson & Johnson Credo etched in marble which stands in the lobby of the company's headquarters in New Brunswick, New Jersey
Our Approach
Year in Brief

5369_-_h4h_report_final_rev1.mp4 (Original).mp4

0:00 / 0:00
Video Companion
5369_-_h4h_report_final_rev1.mp4 (Original).mp4

2021 Year in Brief

Lead with accountability and innovation

$5.22 billion
spent with small and diverse suppliers, exceeding our Health for Humanity 2025 Goal in year one
20% increase
in R&D spend, from $12.2 billion in 2020 to $14.7 billion in 2021
20% increase
in R&D spend
of employees completed Code of Business Conduct training, the highest completion rate to date

Champion global health equity

180 million
doses of our COVID-19 vaccine shipped to the African Union, COVAX and South Africa through advanced purchase agreements and country donations
>2 billion
doses of VERMOX donated since 2006 to facilitate treatment of intestinal worms
U.S. healthcare professionals and researchers provided development and support as part of Our Race to Health Equity commitments*
fistula repair surgeries supported through suture donations in 17 countries

Empower our employees

of employees would recommend Johnson & Johnson as a great place to work
ethnic/racial diversity in management positions within the U.S.

Advance environmental health

reduction in global CO2e emissions
(Scope 1 + Scope 2) since 2016
Race to Zero/Business Ambition for 1.5°C
campaign signed, aiming to achieve net zero carbon emissions by 2045

* Funded in part by the Johnson & Johnson Foundation, a registered charity and a company limited by guarantee, and by the Corporation and operating companies across the Johnson & Johnson Family of Companies. The Foundation operates worldwide as Johnson & Johnson Foundation (founded 1953) and Johnson & Johnson Foundation Scotland (founded 2007).


Included in the FTSE4Good Index Series for the 21st consecutive year
Ranked #7 on Drucker Institute's Top 250 Best-Managed Companies of 2021
Included on TIME's list of the 100 Most Influential Companies
Named as a Top 50 All-Star on Fortune’s 2021 World's Most Admired Companies list for the 19th consecutive year
Ranked #1 on Fortune's 2021 World's Most Admired Companies/Pharmaceutical Industry list for the eighth consecutive year
Recognized by EcoVadis as being in the top 1% for Sustainable Procurement in the rated pharmaceutical industry companies
Recognized with a CDP A List rating for leadership in climate action for the fourth consecutive year
Ranked #3 for the second consecutive year on the Gartner 2021 Top 25 Supply Chain Companies list
Awarded the #1 position on the Gartner 2021 Healthcare Supply Chain Top 25 list
Named on the DiversityInc 2021 Top Companies for ESG list
Included on The Just 100 List for the third consecutive year
Named to the CPA-Zicklin Index of Corporate Political Disclosure and Accountability for the fourth consecutive year with Trendsetter status
Recognized as a “5 Star Employer” in the VETS Indexes Employer Awards
Earned a 100% score in 2021 from the Human Rights Campaign Foundation and designation of a "Best Place to Work for LGBTQ+ Equality"
Previous Message from Our CEO Next Sustainability Governance
Back to Top